Drug Profile
TQ 1015
Alternative Names: TQ-1015Latest Information Update: 28 Jun 2010
Price :
$50
*
At a glance
- Originator TheraQuest Biosciences LLC
- Developer TheraQuest Biosciences
- Class Opioid analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain